More News
11 December 2019
GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery10 December 2019
AbbVie and Scripps Research announce collaboration to develop a broad range of new therapeutics9 December 2019
Merck to Acquire ArQule, Advancing Leadership in Oncology9 December 2019
Healx Joins Forces with Boehringer Ingelheim to Discover New Treatment Approaches for Rare Neurological Diseases8 December 2019
Denovo Biopharma Licenses Global Rights to a Novel Late-Stage Oncology Drug from Sunesis Pharmaceuticals8 December 2019
Janssen to Acquire Investigational Bermekimab from XBiotech6 December 2019
Cerecor to Acquire Aevi Genomic Medicine2 December 2019
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy2 December 2019
Samyang Biopharm USA, Inc and CanCure LLC Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic27 November 2019
Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy26 November 2019
Woolsey Pharmaceuticals Signs License Agreement With Asahi Kasei Pharma for Exclusive Rights to Fasudil25 November 2019
Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis21 November 2019
Vor Biopharma and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Hematopoietic Stem Cells (eHSCs) to Treat Cancer21 November 2019
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical20 November 2019
Excelra Announces a Drug Repurposing Collaboration With Maruho On Dermatological Applications20 November 2019
Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmune Diseases and Oncology19 November 2019
Zelluna Immunotherapy and Glycostem Therapeutics announce partnership to develop allogeneic TCR-NK therapies19 November 2019
Idorsia enters into a collaboration with Antares for the development of a novel self-administered drug-device product for selatogrel19 November 2019
Alkermes to Acquire Rodin TherapeuticsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports